Jeremy Faust saves lives in the ER and breaks stories with his Inside Medicine newsletter. He’s also testing the bounds of ...

An outbreak of diarrhea-causing parasite has grown to more than 1,000 cases, making it one of the nation’s largest such ...

An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs ...

Prime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Mast and Herper have covered rare disease issues for a combined three decades. As part of the reporting, Mast spent two days in the Bay Area with Matt Wilsey and Grace. Jason is a general assignment ...

Longevity entrepreneur Bryan Johnson shared some bad news on social media recently. “I have an autoimmune disease. My stomach ...

Over the past 25 years, I have treated thousands of medical cannabis patients with extremely few ill effects, one doctor ...

We’re here in STAT’s Brooklyn outpost today, where everyone’s gazing across the East River to see whether Pfizer’s former ...

For the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by ...

The White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, empowering the ...

It’s time to bring production of essential medications back to the U.S. — or at least closer to home.  The meeting, described ...